Overview

Incyte is a global, science-driven biopharmaceutical company recognized for its strong growth and deep commitment to advancing therapies in Hematology, Oncology, and Immunology. With a diverse and expanding early pipeline, Incyte is shaping the next generation of targeted and immune-based therapies. Our strength lies in our ability to combine scientific insight with clinical execution, transforming discoveries into impactful medicines for patients worldwide. We are a company in motion, growing, evolving, and investing in early development as a core engine of innovation. At Incyte, every idea begins with science — and every scientist plays a part in shaping what comes next.

The Vice President Global Program Head (GPH) – Dermatology, Immunology is responsible for leading cross‑functional teams to advance early‑stage dermatology and immunology programs. This role owns the integrated product development strategy and ensures delivery of programs aligned with...